Core Insights - Canadian cannabis firms with U.S. exposure are gaining attention due to their ability to bridge both markets, which positions them advantageously as U.S. policy shifts may provide new momentum for growth [1][2][24] - The U.S. legal cannabis market is projected to grow from approximately $37 billion in 2024 to over $91 billion by 2033, indicating a strong annual growth rate of more than 10 percent [2][24] - Recent headlines regarding potential federal reclassification of marijuana have fueled optimism, leading to a rally in cannabis stocks as traders seek follow-through momentum [3][24] Company Summaries Tilray - Tilray is one of the largest cannabis companies globally, focusing on cannabis-adjacent consumer goods in the U.S., with its beverage division being a key growth driver [5][6] - The company reported annual revenue exceeding $820 million, but also a significant net loss of over $2 billion, highlighting the need for tighter cost control despite strong performance in certain divisions [9][11] - The beverage segment achieved gross margins of around 40 percent, indicating strong consumer demand and pricing power [10] Village Farms International - Village Farms operates large-scale greenhouses, supplying cannabis in both Canada and the U.S., with a focus on efficient production rather than retail [12][14] - The company emphasizes wholesale supply to licensed retailers, which reduces capital costs and lowers risk while controlling significant production volumes [12][14] - Recent financial results show steady progress, with Canadian cannabis sales increasing year over year, benefiting from rising demand and improving margins [15][16] Canopy Growth - Canopy Growth is known for its broad product portfolio, including flower, pre-rolls, edibles, and wellness products, and has a presence in the U.S. through licensing and partnerships [17][20] - The company reported strong growth in Canadian medical cannabis sales, reaching $77 million, while international sales showed slight declines [21][22] - Canopy's gross margins expanded by 300 basis points year over year, and it reduced total debt by nearly 50 percent, indicating progress in strengthening its balance sheet [21][22] Market Outlook - The U.S. cannabis market's expansion presents significant opportunities for Canadian firms with U.S. exposure, particularly as potential rescheduling of marijuana could reduce restrictions and enhance valuations [2][24] - Volatility in the sector remains high, making technical analysis and risk management essential for investors looking to participate in the growth story [4][25]

Industry Overview - The cannabis industry continues to attract optimism among investors due to strong financial results from many ancillary and multi-state operators (MSOs) in the U.S. [1][2] - Despite market challenges, companies that remain profitable are seen as long-term investment opportunities, suggesting a potential recovery in the sector [2][3] - Legislative changes, such as rescheduling cannabis or passing banking measures, are anticipated to positively impact market dynamics, given the significant revenue generated in the U.S. [3] Company Highlights - **Planet 13 Holdings Inc.**: Engages in the cultivation and provision of cannabis products for medical and retail markets in the U.S. Recently held its Annual General Meeting, with notable director election results [4][6][7]. - **Greenlane Holdings, Inc.**: Focuses on the development and distribution of cannabis accessories and lifestyle products across multiple regions. Recently appointed Mike Hinson as Executive Vice President of Sales to enhance sales and marketing initiatives [8][10]. - **Jushi Holdings Inc.**: A vertically integrated cannabis company involved in cultivation, processing, and retail. Recently launched a lifestyle cannabis brand named 'Shayo', in collaboration with a reality TV star, aiming to promote wellness [12][13].